The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus

類似資料

• A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up
  著者:: Li, Huiqin, 等
  出版事項: (2019)
• Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52‐week open‐label, randomized phase III trial
  著者:: Wang, Weiqing, 等
  出版事項: (2018)
• Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
  著者:: Suzuki, Shuichi, 等
  出版事項: (2017)
• Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist
  著者:: Smith, Lillian L., 等
  出版事項: (2016)
• A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
  著者:: Lingvay, Ildiko, 等
  出版事項: (2021)